Extremely high-risk patients with acute coronary syndrome: How "extreme" should lipid-lowering therapy be if the LDL-C target <40 mg/dl is considered?

被引：5

作者：

Rallidis, Loukianos S. ^{[1
]}

Tsamoulis, Donatos ^{[2
]}

Leventis, Ioannis ^{[3
]}

Kalogeras, Petros ^{[4
]}

Delakis, Iosif ^{[5
]}

Samiotis, Elefterios ^{[1
]}

Kalantzis, Charalampos ^{[6
]}

Malkots, Belkis ^{[7
]}

Tasoulas, Dimitrios ^{[8
]}

Bouratzis, Vasileios ^{[4
]}

Eleutheriou, Dimitris ^{[9
]}

Dalos, Styliano ^{[10
]}

Potoupni, Victoria ^{[11
]}

Zervakis, Stelio ^{[12
]}

Xygka, Georgia ^{[13
]}

Miliotou, Argyro ^{[14
]}

Papathanasiou, Konstantinos A. ^{[1
,15
]}

Vlachopoulos, Charalambos ^{[6
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Univ Gen Hosp ATTIKON, Med Sch, Dept Cardiol 2, Athens, Greece

[2] Thriasio Gen Hosp, Dept Cardiol, Elefsina, Greece

[3] Univ Gen Hosp Larissa, Dept Cardiol, Larisa, Greece

[4] Univ Hosp Ioannina, Dept Cardiol 2, Ioannina, Greece

[5] Gen Hosp Nikea, Dept Cardiol 1, Piraeus, Greece

[6] Natl & Kapodistrian Univ Athens, Hippokrat Hosp, Med Sch, Dept Cardiol 1, Athens, Greece

[7] Democritus Univ Thrace, Med Sch, Dept Cardiol, Dragana, Alexandroupolis, Greece

[8] Gen Hosp Nikea, Dept Cardiol 2, Piraeus, Greece

[9] Gen Hosp Athens Evangelismos, Dept Cardiol 2, Athens, Greece

[10] Univ Gen Hosp Thessaloniki, Dept Cardiol 1, AHEPA, Thessaloniki, Greece

[11] Aristotle Univ Thessaloniki, Hippokrat Univ Hosp, Dept Cardiol 3, Thessaloniki, Greece

[12] Heraklion Univ Hosp, Dept Cardiol, Iraklion, Greece

[13] Patras Univ Hosp, Dept Cardiol, Patras, Greece

[14] Univ Athens, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece

[15] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Med Sch, Dept Cardiol 2, Athens 12462, Greece

来源：

KARDIOLOGIA POLSKA | 2023年 / 81卷 / 10期

关键词：

D O I：

10.33963/KP.a2023.0147

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1012 / 1014

页数：3

共 48 条

[1] THE EFFECT OF AN INTENSIVE LIPID-LOWERING THERAPY PROTOCOL ON ACHIEVING TARGET LDL-C LEVELS IN PATIENTS WITH ACUTE CORONARY SYNDROME
Seiyama, Kosuke
Oka, Akihiro
Takagi, Wataru
Okada, Tomoaki
Nosaka, Kazumasa
Miyoshi, Toru
Doi, Masayuki
ATHEROSCLEROSIS, 2024, 395
[2] TREATMENT PATTERNS AND LDL-C CONTROL IN VERY HIGH-RISK PATIENTS RECEIVING LIPID-LOWERING THERAPY IN THE UNITED KINGDOM
Beaini, Y.
Danese, M.
Sidelnikov, E.
Villa, G.
Catterick, D.
Iqbal, M.
Gleeson, M.
Lubeck, D.
Patel, J.
VALUE IN HEALTH, 2020, 23 : S499 - S500
[3] Lipid-lowering Therapy and LDL Cholesterol in Patients after acute Coronary Syndrome
Haider, P.
Galli, L.
Schrutka, L.
Distelmaier, K.
Wojta, J.
Hengstenberg, C.
Krychtiuk, K.
Speidl, W.
WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S419 - S419
[4] Lipid-lowering therapy modification and LDL-C Goal achievement after an acute coronary syndrome: a prospective Swiss cohort
Gencer, B.
Mach, F.
Auer, R.
Raeber, L.
Nanchen, D.
Meyer, P.
Matter, C. M.
Windecker, S.
Luescher, T. F.
Rodondi, N.
EUROPEAN HEART JOURNAL, 2013, 34 : 136 - 136
[5] ACHIEVEMENT OF LDL-C GOALS IN PATIENTS AT MODERATE TO VERY HIGH CARDIOVASCULAR RISK ON LIPID-LOWERING DRUG THERAPY (CEPHEUS II)
Logunova, Natalia
Gurina, Natalia
Boytsov, Sergey
ATHEROSCLEROSIS, 2017, 263 : E236 - E237
[6] Should patients with high cardiovascular risk and an LDL-C concentration below 70 mg/dl be treated with aggressive statin therapy?
Lee, Cheol Whan
Park, Seung-Jung
CLINICAL LIPIDOLOGY, 2012, 7 (01) : 1 - 4
[7] Impact of a virtual lipid clinic on lipid-lowering therapy, LDL cholesterol levels, and outcomes in patients with acute coronary syndrome
Garcia, Rafael Vazquez
Garcia, Juan Enrique Puche
Navas, William Delgado
Salmeron, Diego Mialdea
Mateos, Daniel Bartolome
JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (05) : 635 - 642
[8] Are coronary patients on lipid-lowering therapy in Europe achieving the recommended LDL-C target? Results from the Dyslipidemia International Study (DYSIS) II Europe
Gitt, A. K.
Ferrieres, J.
De Ferrari, G.
Elisaf, M.
Hermans, M. P.
Kiernan, T.
Oganov, R.
Lautsch, D.
Ashton, V.
Ambegaonkar, B.
EUROPEAN HEART JOURNAL, 2015, 36 : 286 - 286
[9] Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design
Boulmpou, Aristi
Kartas, Anastasios
Farmakis, Ioannis
Zafeiropoulos, Stefanos
Nevras, Vasileios
Papadimitriou, Ioannis
Tampaki, Athina
Vlachou, Anastasia
Lillis, Leonidas
Koutsakis, Athanasios
Karvounis, Haralampos
Giannakoulas, George
HELLENIC JOURNAL OF CARDIOLOGY, 2019, 60 (04) : 249 - 253
[10] VARIABILITY OF THE LDL-C RESPONSE TO TWO INTENSIVE LIPID-LOWERING THERAPY REGIMENS IN PATIENTS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
Li, Ya
Jin, Jinhua
Zhang, Wenbin
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 151 - 151

← 1 2 3 4 5 →